NYSE:CAHHealthcare
How Investors Are Reacting To Cardinal Health (CAH) Raising Guidance While Expanding Theranostics Amid Recall
Earlier this week, Cardinal Health reported Q3 fiscal 2026 results that exceeded estimates and raised its full-year adjusted EPS and free cash flow guidance, alongside updates on theranostics expansion and a voluntary recall of certain alcohol prep pads.
The combination of upgraded outlook and continued investment in its Center for Theranostics Advancement highlighted management’s confidence in Cardinal Health’s higher-value growth initiatives, even as the company managed operational and...